Acquired Willebrand's syndromes associated with lymphoproliferative disorders;Syndrome de Willebrand acquis avec desordres lymphoproliferatifs

Presse Medicale

Volumn 26, Issue 1, 1997, Pages 12-14

  Hamidou, M ^a   Agard, C ^a   Fressinaud, E ^a   Fiks Sigaud, M ^a   Rapp, M J ^a   Grolleau, J Y ^a   Harousseau, J L ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN KAPPA CHAIN;

ADULT; AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; LYMPHATIC LEUKEMIA; LYMPHOPROLIFERATIVE DISEASE; MALE; PERTHES DISEASE; VON WILLEBRAND DISEASE;

ADRENAL CORTEX HORMONES; AGED; CHRONIC DISEASE; EMERGENCIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; VON WILLEBRAND DISEASE;

EID: 0031052468     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ribba AS, Lavergne JM, Girma JP, Meyer D. Bases moléculaires de la maladie de Willebrand. Hematologie 1995; 1:191-8.
2. Fressinaud E, Meyer D. La maladie de Willebrand : du diagnostic au traitement. Hematologie 1995 ; 1:199-208.
3. Rothschild C, Meyer D. Syndrome de Willebrand acquis. In: Les 365 nouvelles maladies. Flammarion 1989 ; 573-6.
4. Ruggeri Z, Ware J. The structure and function of von Willebrand factor. Thromb Haemost 1992 ; 67:594-9.
5. Mannucci PM, Lombardi R, Bader R et al. Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies. Blood 1984 ; 64:614-21.
6. Girma JP, Kalafatis M, Pietu G et al. Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies. Blood 1986; 67:1386.
7. Pareti FI, Niiya K, McPherson JM, Ruggeri ZM. Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III. J Biol Chern 1987 ; 262:13835-41.
8. Van Genderen PJJ, Vink T, Michiels JJ, Van't Veer MB, Sixma JJ, Van Vliet HHDM. Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen. Blood 1994 ; 84:3378-84.
9. Richard C, Cuadrado MA, Prieto M et al. Acquired von Willebrand disease in multiple myeloma secondary to absorption of von Willebrand factor by plasma cells. Am J Hematol 1990 ; 35:114-17.
10. Rodeghiero F, Castaman G, Mannucci PM. Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand disease. Blood Rev 1991 ; 5:155-61.
11. Van Genderen PJJ, Papatsonis DNM, Michiels JJ, Wielenga JJ, Stibbe J, Huikeshoven FJM. High-dose intravenous gammaglobulin therapy for acquired von Willebrand disease. Postgrad Med J 1994 ; 70:916-20.